2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritisJasvinder A. Singh, Kenneth G. Saag, Daniel E. Fürst et al.|Arthritis Care & Research|2012Cited by 1.8k
Abatacept for Rheumatoid Arthritis Refractory to Tumor Necrosis Factor α InhibitionMark C. Genovese, Maxime Dougados|New England Journal of Medicine|2005Cited by 1.2k
EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)Bernard Combe, Hasan Yazıcı, J. M. W. Hazes et al.|Annals of the Rheumatic Diseases|2006Cited by 798
Histomorphometric effect of six month treatment with oral risedronate in patients with multiple myelomaMartine Cohen‐Solal, M.C. de Vernejoul, Christian Roux et al.|Bone|1993Cited by 14